Kaposi Sarcoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Kaposi Sarcoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Kaposi Sarcoma Local Doctors?
Elite in Kaposi Sarcoma
Dermatology
Elite in Kaposi Sarcoma
Dermatology
1520 Stockton St, 
San Francisco, CA 
Languages Spoken:
English

Toby Maurer is a Dermatologist practicing medicine in San Francisco, California. Dr. Maurer is rated as an Elite provider by MediFind in the treatment of Kaposi Sarcoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Kaposi Sarcoma, Acute Febrile Neutrophilic Dermatosis, Bullous Pemphigoid, Psoriasis, and Tissue Biopsy.

Elite in Kaposi Sarcoma
Dermatology
Elite in Kaposi Sarcoma
Dermatology
50 Staniford St Fl 2, 
Boston, MA 
Languages Spoken:
English

Esther Freeman is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Freeman is rated as an Elite provider by MediFind in the treatment of Kaposi Sarcoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Kaposi Sarcoma, Perniosis, Frostbite, Monkeypox, and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Kaposi Sarcoma
Elite in Kaposi Sarcoma
Zurich, ZH, CH 

Matthias Egger practices practicing medicine in Zurich, Switzerland. Mr. Egger is rated as an Elite expert by MediFind in the treatment of Kaposi Sarcoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Kaposi Sarcoma, Aspergillosis, Mucormycosis, and Hepatectomy.

What are the latest Kaposi Sarcoma Clinical Trials?
Phase II Basket Study to Evaluate the Tissue-agnostic Efficacy of Anti-Programmed Cell Death Protein 1 (Anti-PD1) Monoclonal Antibody in Patients With Advanced Rare Tumors

Summary: The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with advanced or metastatic rare tumors. The study aims to treat rare malignancies with PD-L1 expression (CPS ≥ 10), regardless of the tumor's tissue type or location. Patients who have not responded to standard treatments will be included, and ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer

Summary: BACKGROUND: * A number of important scientific advances can be made through the study of blood, bone marrow, tumor, or other tissue samples from patients with HIV infection, infection with Kaposi s sarcoma associated herpesvirus (KSHV), infection with other oncogenic viruses, or cancer. * This protocol provides a mechanism to affect a variety of such studies. OBJECTIVES: -Acquisition of serum, cir...